Anixa Biosciences Income Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Revenue	0.21	0	0.51	0	0.25	1.11	0.36	0.3	9.26	3.67	Upgrade
Revenue Growth (YoY)	-	-	-	-	-77.53%	206.90%	20.83%	-96.76%	152.36%	843.12%	Upgrade
Cost of Revenue	0.16	0	0.39	0	0.17	0.77	0.1	0.22	3.65	1.99	Upgrade
Gross Profit	0.05	0	0.13	0	0.08	0.34	0.26	0.08	5.61	1.68	Upgrade
Selling, General & Admin	6.29	7.17	7.07	5.6	5.66	6.91	4.41	2.71	5.51	6.41	Upgrade
Research & Development	4.77	6.7	6.19	4.38	5.47	6.81	1.6	1.56	0.71	0	Upgrade
Other Operating Expenses	0	0	0	0	0.84	0.91	0.33	0.33	0.33	0.31	Upgrade
Operating Expenses	11.06	13.88	13.26	9.98	11.97	14.63	6.33	4.59	6.55	6.72	Upgrade
Operating Income	-11.01	-13.88	-13.14	-9.98	-11.89	-14.29	-6.08	-4.51	-0.94	-5.04	Upgrade
Interest Expense / Income	0	0	0	0	0	0	0.5	0.52	0.45	1.26	Upgrade
Other Expense / Income	-1.2	-0.28	-0.18	0.04	-0.24	-0.29	-1.57	-0.01	-0.02	3.3	Upgrade
Pretax Income	-9.81	-13.6	-12.95	-10.02	-11.65	-14	-5.01	-5.02	-1.38	-9.61	Upgrade
Net Income	-9.81	-13.6	-12.95	-10.02	-11.65	-14	-5.01	-5.02	-1.38	-9.61	Upgrade
Preferred Dividends	0	0	0	0	0	0	2.01	0	0	0	Upgrade
Net Income Common	-9.81	-13.6	-12.95	-10.02	-11.65	-14	-7.02	-5.02	-1.38	-9.61	Upgrade
Shares Outstanding (Basic)	31	30	29	22	20	18	12	9	9	9	Upgrade
Shares Outstanding (Diluted)	31	30	29	22	20	18	12	9	9	9	Upgrade
Shares Change	2.00%	6.28%	28.57%	12.33%	12.29%	44.49%	39.57%	-0.24%	0.57%	10.74%	Upgrade
EPS (Basic)	-0.32	-0.45	-0.45	-0.45	-0.59	-0.79	-0.58	-0.57	-0.16	-1.10	Upgrade
EPS (Diluted)	-0.32	-0.45	-0.45	-0.45	-0.59	-0.79	-0.58	-0.57	-0.16	-1.10	Upgrade
Free Cash Flow	-6.21	-6.49	-4.9	-6.19	-4.92	-4.31	-3.78	-3.53	1.31	-2.39	Upgrade
Free Cash Flow Per Share	-0.20	-0.21	-0.17	-0.28	-0.25	-0.24	-0.31	-0.40	0.15	-0.27	Upgrade
Gross Margin	23.33%	-	24.80%	-	33.50%	30.93%	71.16%	27.53%	60.58%	45.79%	Upgrade
Operating Margin	-5243.33%	-	-2565.63%	-	-4756.00%	-1284.41%	-1676.02%	-1503.00%	-10.21%	-137.54%	Upgrade
Profit Margin	-4671.90%	-	-2530.08%	-	-4658.82%	-1258.07%	-1935.94%	-1672.14%	-14.90%	-261.94%	Upgrade
Free Cash Flow Margin	-2956.67%	-	-957.62%	-	-1966.75%	-387.58%	-1043.28%	-1176.07%	14.14%	-65.06%	Upgrade
EBITDA	-9.77	-13.55	-12.89	-9.93	-11.6	-13.98	-4.47	-4.46	-0.91	-8.34	Upgrade
EBITDA Margin	-4650.00%	-	-2518.36%	-	-4639.80%	-1256.41%	-1231.81%	-1487.72%	-9.88%	-227.49%	Upgrade
Depreciation & Amortization	0.05	0.04	0.06	0.09	0.05	0.02	0.04	0.03	0.01	0	Upgrade
EBIT	-9.81	-13.6	-12.95	-10.02	-11.65	-14	-4.51	-4.5	-0.93	-8.34	Upgrade
EBIT Margin	-4671.90%	-	-2530.08%	-	-4658.82%	-1258.07%	-1243.73%	-1498.83%	-10.02%	-227.49%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).